Concurrently, somatic TP53 mutations were identified in tumours (5, 6) and germ-line TP53 mutations were described in the Li-Fraumeni syndrome (LFS), the well-known hereditary cancer predisposition disorder (7). This evidence concerns the gene TP53 and Li-Fraumeni syndrome.